MannKind to Acquire scPharmaceuticals for $360 million
On Aug. 25, 2025, MannKind and scPharmaceuticals announced the signing of a definitive merger agreement for MannKind to…
-
-
C2N Diagnostics Expands the PrecivityAD2™ Alzheimer’s Disease Blood Test Intended Use to Patients 50 Years and Older
On Aug. 25, 2025, C2N Diagnostics (C2N) announced lower age limit addresses increasing calls from clinicians seeking access…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | NIH | Therapeutics | USDA
U.S. confirms nation’s first travel-associated human screwworm case connected to Central American outbreak
On Aug. 24, 2025, the U.S. Department of Health and Human Services reported the first human case in…
-
Award-winning HIV scientist Shan Liang leaves U.S. to join Chinese research institute
On Aug. 23, 2025, award-winning HIV scientist Shan Liang, a tenured associate professor at the Washington University School…
-
Mayo Clinic research set to launch aboard NASA mission to International Space Station to explore new therapies for bone loss
On Aug. 22, 2025, the Mayo Clinic announced that its pioneering exploration of stem cell-based therapies for bone…
-
Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform
On Aug. 21, 2025, Kite, a Gilead Company company, announced that it has entered into a definitive agreement…
-
Johnson & Johnson to Invest $2 Billion at State-Of-The-Art North Carolina Facility
On Aug. 21, 2025, Johnson & Johnson announced it will increase its presence in North Carolina with a…
-
Artificial Intelligence | Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics
CPRIT Approves $27 Million In Grants for Cancer Research in Texas
On Aug. 20, 2025, The Cancer Prevention and Research Institute of Texas (CPRIT) announced the approval of 15…
-
Biggest shake-up in type 2 diabetes care in a decade announced
On Aug. 20, 2025, the National Institute for Health and Care Excellence (NICE) announced that millions of people…
-
5th death linked to Legionnaires’ disease outbreak that has sickened dozens in New York City
On Aug. 19, 2025, health officials have uncovered another death in connection with a Legionnaires’ disease outbreak in…
-
Lewis and Clark County, Montana Health Officials Report First Measles Case in Decades
On Aug. 18, 2025, Lewis and Clark Public Health (LCPH) officlials in Montana have confirmed a single case…
-
In a Major Win for Vanda, a Federal Appeals Court Overturns FDA’s Order Denying Approval of Hetlioz for the Treatment of Jet Lag Disorder
On Aug. 18, 2025, Vanda Pharmaceuticals announced that it secured a landmark victory over the U.S. Food and…
-
Texas announces end of West Texas measles outbreak
On Aug. 18, 2025, the Texas Department of State Health Services is reporting the end of this year’s…
-
Skyhawk Therapeutics Announces Strategic Collaboration with Merck to Discover Novel RNA-Targeting Small Molecules for Neurological Disorders
On Aug. 18, 2025, Skyhawk Therapeutics announces a strategic research collaboration with Merck KGaA, Darmstadt, Germany. The collaboration…
-
Biotechnology | Disease | FDA | Medicine | Therapeutics
Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients
On Aug. 18, 2025, Novo Nordisk announced the launch of a new offer that enables self-paying, eligible, type…
-
Biotechnology | Diagnostics | Infectious Disease | Measles | Vaccine | WHO
Nepal Eliminates Rubella, Also Known as German Measles
On Aug. 18, 2025, the World Health Organization announced Nepal has eliminated rubella as a public health problem,…
-
Biotechnology | Disease | FDA | Therapeutics
Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
On Aug. 15, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved a…
-
Human embryo implantation recorded in real time for the first time
On Aug. 15, 2025, researchers at the Institute for Bioengineering of Catalonia (IBEC) in collaboration with the Dexeus…
-
Precigen Announces FDA Approval of PAPZIMEOS, the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis
On Aug. 15, 2025, Precigen announced that the US Food and Drug Administration (FDA) has approved PAPZIMEOS™ (zopapogene imadenovec-drba)…
-
OHSU Knight Cancer Institute receives record $2 billion commitment from Phil and Penny Knight
On Aug. 14, 2025, Phil and Penny Knight announced a record-breaking $2 billion gift to the Oregon Health…
-
Valley Fever Cases Continue to Rise in 2025 Following Record High in 2024
On Aug. 14, 2025, the California Department of Public Health (CDPH) is reminding California residents and visitors that…
-
4th person dies after a Legionnaires’ disease outbreak sickens dozens in New York City
On Aug. 14, 2025, a fourth person has died in connection with a Legionnaires’ disease outbreak in New…
-
Artificial Intelligence | Biotechnology | Infectious Disease | Medical Device | Nanotechnology | Pharmaceutical
China creates new visa for young STEM talent in national tech drive
On Aug. 14, 2025, China announced it had launched a new visa category for young science and technology…
-
Researchers Map Cellular Landscape of the Developing Human Lung
On Aug. 13, 2025, a research team led by investigators at the Translational Genomics Research Institute (TGen), part…
-
AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in Illinois
On Aug. 12, 2025, AbbVie announced a $195 million investment in its North Chicago, Illinois manufacturing plant to…
-
Tick, Tick, Boom: Never-Before-Seen Images of Tick-Borne POWV Virus Could Light Fuse for New Treatments
On Aug. 12, 2025, Powassan virus (POWV), a type of flavivirus closely related to the Zika and Dengue…
-
Bayer and Kumquat Biosciences enter global $1.3 Billion license and collaboration in precision oncology
On Aug. 12, 2025, Bayer and Kumquat Biosciences, a clinical-stage biotech company founded by pioneers of the KRAS…
-
Researchers identify a potential biomarker for long COVID
On Aug. 11, 2025, Researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, and…
-
Researchers test common Household disinfectants’ abilities to fight antibiotic resistance at the genetic level
On Aug. 11, 2025, University of Washington (UW) researchers announced the results of testing the efficacy of several…
-
Will China’s new chromosome editing tool unlock new wave of genetic advances?
On Aug. 10, 2025, a group of Chinese scientists has overcome a challenge that stumped biologists for decades…
